Reuters logo
Hikma expects revenue to rise 13 pct in 2013
May 16, 2013 / 6:56 AM / 5 years ago

Hikma expects revenue to rise 13 pct in 2013

May 16 (Reuters) - Hikma Pharmaceuticals Plc raised its full-year revenue forecast, saying its generic antibiotic doxycycline was generating revenue ahead of its expectations.

The company said it expected group revenue to rise about 13 percent in 2013, up from previous forecast of around 10 percent

Hikma reported revenue of $1.11 billion in 2012.

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below